News
June 17, 2025
3 Boomerang Portfolio Company Acquires Pinnaql as First Step to Scale Best-in-Class Consulting Platform for Guiding Clients Through Complex Regulatory Environments
Learn moreJune 10, 2025
3BC's Funding & Support Fuels Company's Growth While Scaling and Optimizing Production of Key Components to Medical Device Manufacturers
Learn moreJune 3, 2025
3 Boomerang Capital, LP ("3BC"), a healthcare-focused, lower-middle-market private equity firm, today announced the launch of LSOMS Holdings, L.P.
Learn moreMarch 25, 2025
Leading Provider of Regulated Biomedical Waste Solutions, Designed to Be Energy-Efficient & Environmentally Responsible, Receives Strategic Resources & Capital to Continue Rapid Growth
Learn moreJanuary 23, 2025
3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused private equity firm committed to driving transformative growth for lower middle-market businesses, is proud to announce the appointment of Martin LeBlanc as chairman of its Strategic & Operational Advisory Board.
Learn moreDecember 5, 2024
Enjoin, LLC ("Enjoin" or the "Company") is pleased to announce that experienced healthcare leader Steve Hynes has joined its Board of Directors (the "Board") as executive chairman.
Learn moreNovember 21, 2024
3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused, lower middle-market private equity firm, announces a majority growth investment in Enjoin, LLC ("Enjoin" or the "Company"), a leader in Clinical Documentation Integrity ("CDI") solutions for hospitals and health systems nationwide.
Learn moreJune 24, 2024
3 Boomerang Capital has announced a strategic growth investment in Analytical Biological Services Inc. (ABS), marking the first platform investment of its newly closed Fund I.
Learn moreFebruary 6, 2024
3 Boomerang Capital Raises Over $375 Million for Healthcare Private Equity Fund, Exceeding Target
Learn more